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Sulphur mustard belong~ to a class of agents
which rcadily alkylatc ccllulur DNA, RNA und
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I
The effect of single dennal application of different doses of sulphur mustard (2,2'-dichlorodiethyl
sulphide, SM), i.e.'5, 10 and 20 fig/kg body weight on some physiological variables, viz., body weight,
intake of food and water, and excretion of excreta and urine was studied f<?r one week. Levels of urinary
metabolites, uric acid, urea, protein, creatine and creatinine were measured at 0, 1,2, and 7 days in
albino rats of Wister strain. A progressive dose-dependent fall in body weight was observed from day
l'onwards after SM application. Feed and water intake were reduced significantly. Excretion of urine
and exc'reta was also affected adversely. The level of uric acid, 11 metabolite of purine bases, increasedI
2;. hr post-exposure, in a time and dose-dependent manner. Excretion of urea decreased and the level
of creatine increased drastically on 71h day .However, urinary excretions of protein and creatinine did
I
'ot change. The s~dy show~ that single application of SM in rats induces a catabolic state.
I ;. .,
INTRODUCT~ON !
I
Sulphur mustard (2,2'-~ichlorodiethyl
l1ide, SM) is a potent vesicant and an alkylatingI
ti. It ~as been stockpiled for use as a chemical
are agbnt in a number of 1ountries and reports
lvailable of its recent use. Knowledge of the
)gical fate of SM : is important to develop
Isic methods to confirm and detect mustard
)ning i~ victims of chemical attacks. There are
ral reports3-S on d~stribution, metabolism and
ination of SM. Su,phur mustard reacts in an
:ous phase with compound$ cont'aining
eophilic functionall groups like amino,
Iydryl, catboxylic and' hydroxyl groups in
:ins. The tpxicity of SM has beerl assume.d to
t from interaction with one or more differen~
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proteinsu", The DNA appears to be a critical target
and alkylation of nucleic acid is an early molecular
event in SM-induced toxicity. Alkylation of DNA
by SM adducts occurs at N- 7 position of guanine
and at N-3 position of adenines. Bifunctional
adducts involve at N,- 7 position two adjacent
guanine or two guanine groups situated on opposite
strands9, which leads to DNA strand break. The
DNA breaks caused by mustard activate the
chromosomal enzymes poly ,(ADP-ribose)
polymerase. Activation of poly (ADP-ribose)
polymerase consumes more available NAD+ as its
substrate to ADP ribosylate, a variety of nuclear
proteins, which causes depletion of cellular NAD+,
inhibit glycolysis, interfere with energy
metabolism and eventually cause cell death 10.11.
~CVCfIllIlllli(I()IC1) rOf SM llllVC bccll 1)C.:rccllcd,
but they have found to give' only marginal
protcotion. Dccontamination of S from the skin
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2,5 Phy!iloloflcul Vurlublcs
The animnls were kept individually I day prior
I
I~) Cxp()slirc ill II IIICIIII)olic CII!~C. IJoJy wciglll, fl'l'J
intalqe, water intake, urine volumr and excreta
volume (s~lid matter) of animals of' all the groupst Iwere recorded daily. t
is fuulld tu bl: .tIll: IllUSt l:ffiCil:llt Illl:tllUd fur
reducing toxicity. t
I11 IIi<.: pr<.:sl:111 iIIV<.:Slig.lliull w<.: IljlVl' slllJi~tl
the effect of single dermal application of SM to rats
on physiological variables and urinary metabolites
at different time intervals.
MATERIALS & METHODS2.
,
2.6 BlocIlC1Ulcul Anulyslsl
Urine samples were co~lected on 0, 1, 2, and 7
days of exposure and urine analysis wat carried out
for uric acid, urea, protei~ creatine and 'creatinine.
Uric acid was determined Iby phosphotungstic acid
methodl3 and urfja by dihcetyl monoxime
h d l4 C . d ..J .
dmet o , reatlne an creatlnlne wer1 estImate
by picrate methodls and protein by Folin'sI
methodl6,
2.1 Chemicalsf
The puri(y of SM, synthesised in the
I
Establishment, was > 95 Ptfr cent, as estimated by
gas chromatography. All otheichemicals used were
of analytical gr1lde (Sigma/Emerck/BDH/SRL).I
2.2 Animals
Adult female albino ruts of Wister struil1, bred
at the Defence Research & Development
Establishment (DRDE), Gwalior, weighing
120-140 9 were used. The rats were maintained on
standard (AMRUT) rodent chow. Food anti water
were given ad libitum.
J
2.7 StutisticullAnulysis ,
Repeated rheasures of ANOVA with Dunnett's
mu~tiple comptlrison vJere ured to dvaluate the
differences between the control and Txperimental
groups. For this, SigmaStat, Version 1.0 was used.
.
A probability of less than 0.05 was taken as
,statistically significant. I ,
3. RESULTS & DISCUSSION
LD5o val\les for dermal administration of SM
t,o fe~ale rats are presented in Table 1. The results
indicate that LD5o value d,ecreases with increase in
the observation period.
,
Dermal administrati'on ofSM to rats affects the
physiological ,variables! SM-induced significant
decrease tin body \'(eight in a. time and
dose-dependent mann~r (Fig. I ). Decrease in body
,
Table I. LD50 values ror 'sulphur mustard in rat
--I. c
Period of LOso 95 % confidence limit
observation (mg/kg) ,
2.3 Determination of LDso
r
The median lethal concentration (LDso) with
95 per cent confidence limits of SM was
determined by the method of Gad and Wie111, For
this, the hair on the back of the rat were closely
clipped and SM was applied on the skin. The
animals were observed for mortality till 141h day.
2.4 Treatment
The animals were divided into four groups of
six each. The SM was diluted in PEG-300 and three
different doses of SM, 5, 10 and 20 fig/kg body
weight, were applied uniformly on the back of the
rats on a circular area of 2 cm diameter, after
closely clipping the hair of rats of groups 2, 3 and
4, respectively. In group I (~ontrol) animals, only
0.1 ml of PEG-300 was applied in the same manner.
203.51
22.98.
5.57.
3.27.
1 day
3 days
7 days
320.00
40.00
12.60
5.9~
,
,
14 days
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-503.18
.69.63
.28.52
.10.82
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Figure I. Changes In body weight rollowing sinl:le dermal
application or s M jn female rat. Values are'mean :t S E
or 6 animals. Statistically signilicant by RM ANOVA.
Body weight: Dose p < 0.001, day aner exposure
p < 0.001,
I
weight, continued. till death of the animals.
Decrease in' body weight was a consistent
.
observat!ion. Dose-dependent decrease in the body
I
weight of mice after SM app~ication was reportedI I 17 I
by Vel1katesw~ran, e! al .This reduction was
prominent in t~e group that wAs administered SM
in higher doses. The reducti~n may be due to
change in appetite and intestin~1 absorption, or to
I
the arrbst of cellular proliferation in gut epithelium,
becau.Je SM is an antimitotic and cytostatic
1718 .I
agent. .Foo~ Int..ke and' excreta volume also
d~creased significarltly 24 hr after SM administ-
I
ration ~t all dose levels. This decrease may be due
to chante in appetite or physical stress exerted by
SM. Water intake; and urine volume were also
affected adversely I(Fig. 2). There is decrease in
I
food and water int~ke at at1 dose levels in
comparison to the control animals. Lack of dose-
I I
dependent\response with regard to food ard water
intake may bf due to SM induced physiological
l,'hanges at both low and high dose levels.
,
The fesults of the p;resent study indicate that
purine metabolism incrcases after SM exposure,
~ 8
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Figure 2. Observations following single dermal application of
SM in female rat. Food intake and excreta expressed
as g/24 hr and water intake and urine volumes as
ml/24hr. Vulues are mean of 6 animals. Statistically
sil:nificunt by I{M ANO\:A. Food intake: Dose
I' < 0.001, I)ay IIrter exposurCt I' < O.QO 1. Excreta: Dose
p < 0.01, Day after exposure p < 0.001. Water intake:
Dose p < 0,001, dlly after exposure p < 0.001, Urine:
Dose NS, duy Jlrter exposure I' < 0,0,1.
.
resulting in increased excretion of uric dcid.
,
Increased excretion of uric acid was observed 24 hr
post-exposure and continued tlll 71h day in a dose
and time-dependent manner (Fig. 3}. Increase in
uric acid level was due to increased apurination of
DNA, as SM is a known DNA alkylating agentl,
Bifunctional adducts are involved at N- 7 position
of two adjacent guanine groups or two guanine
groups silualed on OppOSilC slrunds9, which leads
to apurination, Apurinated bases were first
1IIl.lal,llli~L,1 1(1 Ilypllxalllllilll:, IIICII III XlllllllillC 1IIill
finally to uric acid. Increasc in uric acid level was
not associ:ltrd wilh sl:lrv:llio'n, In sl:lrvalion, uric
a,-,id level deCretISesl'). 'I'ltere was a decrease in theI
391
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I
CONTROL 5 mg/kg 10 mg/kg 20 mg/kg
Figure 3. Effect of SM following single dermal application on
urinary urea (g/24hr) and uric acl~ (mg/24tlr). Values
are mean :t. SE of6 animals. Statistically slgnincant by
RM ANOVA. Urea: Dose NS, day ~rter exposure
p < 0.01. Uric acid: Dose p < 0.01, day aner exposure
p < 0.001.
level of urea (Fig. 3). Most of the ammonia formed
by deamination of amino acids in the liver is
converted to urea, which is excreted in -urinel9.
Decreased urinary excretion may be due to
pronounced kidney and liver disorders or decreased
urea formation and decreased power of these
I ..19 E . f . organs to e Immate urea. xcretlon O urInary
creatine (Fig. 4) increased significantly after 71h
day of exposure. This increase may be associated
with disintegration of muscular tissue or fasting, as
food consumption is significantly reduced in these
conditions. However, levels of creatinine (Fig. 4)
and protein (data not given) were not affected. The
result of the present study I shows that a single
dermal application of SM in rat induces a catabolic
state.
ICONTROL 5 mg/kg I 10 mg/kg 20 mg/kg
I
Figure 4. Effect of SM following single dermal application on
urin ary excretion of creatine (mg/24hr) and creatinine
(mg/24hr). Values are mean :t SE of 6 animals.
Statistically slgnlffcant by RM ANOVA. Creatine:
Dose NS, day after exposure p < 0.001. Creatinine:
Dose NS, day after exposure p < 0.05.
I
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